The performance of companies tied to Sildenafil's past presents a challenging investment landscape. While the initial surge generated substantial returns , generic alternatives have significantly eroded https://knockoff416825.ziblogs.com/42075737/the-copyright-and-big-pharma-a-uncertain-opportunity